Benefits include effective treatment of prostate cancer or BPH, relief from symptoms, and potential improvement in quality of life.

Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.

EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.

Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.

EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.

Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.

HBsAg is a surface antigen of the hepatitis B virus, detected in the blood during HBV infection.

Individuals at risk of HBV infection or needing routine screening should undergo this test.

No, the test involves a simple blood draw, which may cause slight discomfort but is generally well-tolerated.

A positive result indicates the presence of HBV infection.

No, additional tests may be required to distinguish between acute and chronic infection.